TACC3 and neoplasm: Finally, although FGFR inhibitors abrogated PD1/PD-L1-mediated T cell suppression (Supplementary Fig. S3), their effects on primary immune cells or the microenvironment in murine tumor models harboring FGFR3-TACC3 fusion warrant further investigation.